Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma

Abstract

The current study data suggested that patients treated with intensive therapies did not fare better than those treated with CHOP therapy. New treatment regimens need to be developed for patients with T-NHL.